soft tissue tumours, benign osteomas and intestinal polyposis; 2 some patients are reported to exhibit extrabowel lesions only. 3 Proposed markers for Gardner syndrome include skin tumours, most commonly multiple epidermal cysts 4 and osteomas which have been reported in 50% of the patients. 5 Congenital hypertrophy of the retinal pigmented epithelium (CHRPE), 6 dental malformation, 7 and benign cystic lung tumours 8 represent facultative signs. The most deleterious disease phenotypes are Gardner-associated malignant tumours, such as those affecting the colon, 9 and to a lesser extent other tissue sites. [10] [11] [12] Gardner syndrome and familial adenomatous polyposis (FAP) traits map to the same chromosomal locus 13, 14 and may share the same somatic, as well as germline, adenomatous polyposis coli (APC) gene mutations, which has also been reported for flat adenoma syndrome and Turcot syndrome. [15] [16] [17] The APC gene resides on chromosome 5q21, is composed of 15 exons spanning > 8AE5 kb and encodes a 2843-amino acid polypeptide. 18 In the present analysis, we investigated whether germline APC gene mutations or major chromosomal deletions may be identified in a patient with multiple epidermal cysts, osteomas and a thyroid gland nodule, lacking intestinal polyposis.
Case report and methods
A 36-year-old male patient presented with multiple cystic and nodular lesions on the face, neck and left ear lobe, reporting an increasing number and size of nodules since the age of 20 years. The lesions were occasionally inflamed and white masses could be expressed after incision. The patient had been reported to suffer from nodulocystic acne or steatocystoma multiplex before he was referred to the Department of Dermatology, University Medical Center Benjamin Franklin, Freie Universität Berlin (Berlin, Germany). A detailed physical examination was performed and, after the patient gave informed consent, venous blood samples were taken for subsequent genetic analyses.
A cytogenetic analysis using comparative genomic hybridization (CGH) with 650 chromosomal bands per haploid set was performed to identify chromosomal deletions, essentially as previously described. 19 Genomic DNA from the population sample was prepared from white blood cells by phenol extraction and from the study patient by using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany 20 for the APC polymorphisms A545A, G1678G, S1756S, P1960P and D1822V was performed using allele-specific oligonucleotides (ASO) as previously described. 21 
Results
Physical examination revealed multiple cutaneous cysts sized 3-10 mm, mainly on the cheeks and under the chin, as well as several large skin-coloured nodules on the preauricular area, on the neck and left ear lobe (Fig. 1) . The latter was a 20-mm large nodule with multiple telangiectases (Fig. 2) . Numerous scars were present. Additionally, elastotic skin areas with large closed and open comedones were present at the zygomatic regions typical for Favre-Racouchot syndrome; these were unusual for his age but typical for his history of a craftsman working outside for many years. Biopsies of several lesions showed numerous cystic cavities within the deep dermis or subcutis lined by a wall of stratified squamous epithelium. The epithelium contained a granular layer, including areas with a markedly atrophic wall in the larger cysts. The cysts were filled with keratin material arranged in laminated layers (Fig. 3 ).
X-rays of the skeleton detected two osteomas in the left ulna of 0AE5 cm and in the radius of 2 cm (Fig. 4) . The skull, orbits and other tabular bones were inconspicuous. Ultrasound and scintigraphy of the thyroid gland showed multilocular lesions; the right lobe contained a cold nodule, the left a hot nodule and the isthmus carried a cyst. Malignancy was excluded by fine needle biopsy. No abnormalities were seen by electrocardiography, colonoscopy, gastroscopy or by colon contrast radiography. Chest X-ray, abdominal computed tomography and eye examination were also normal.
Laboratory examination revealed a normal full blood count, erythrocyte sedimentation rate, C-reactive protein and electrolytes as well as renal values, liver enzymes and thyroid gland values in the serum. The following were pathologically elevated: cholesterol
and triglycerides 3AE46 mmol
No information about the family history was available. The systematic scan of > 8500 bp of the APC gene of the patient and five healthy controls resulted in the identification of the following previously unpublished APC gene polymorphisms (all of which were silent): (Table 1) ; amino acid positions refer to the reference sequence NM000038. The respective frequencies of the less frequent alleles of A545A, G1678G, S1756S and P1960P were: 0AE38, 0AE34, 0AE37 and 0AE37, as calculated after genotyping 194 samples (Table 1) . Our index patient was heterozygous for all these variants. Amplimer and ASO sequences used to genotype for APC gene variants are given in Table 2 . Specific hybridization conditions are available upon request.
We also identified the already published APC D1822V (A ⁄ T) polymorphism which has been reported to be potentially related to colorectal carcinoma, and genotyped 194 samples for this variant. As a result, we found that 112 subjects carried the 1822 DD (57AE7%), 71 the DV (36AE6%), and the remaining 11 (5AE7%), as well as our patient, the VV genotype. Additionally, major chromosomal deletions, but not deletions in the range of kbp, were excluded by CGH analysis.
Discussion
A 36-year-old patient presented with multiple epidermal cysts on the head and neck as well as a cold nonmalignant nodule of the thyroid gland and two osteomas in the radius and ulna. Typical intestinal disease manifestations were lacking at the time of examination.
In both the cytogenetic analysis and the systematic genetic scan of the entire coding sequence of the APC gene, we failed to identify major deletions as well as obvious candidate germline mutations, respectively. With respect to the complexity of the genetic and clinical basis of Gardner syndrome, some crucial aspects should be addressed. From a clinical point of view, it cannot be excluded that the patient may develop intestinal disease manifestations later in life (late-onset) or with a mild disease course, occasionally escaping routine detection. From a genetic point of view, we encounter a more complex scenario: (i) our cytogenetic analysis did not exclude minor deletions, and (ii) at least 5% of genetic alterations predisposing to FAP have been assigned to allelic imbalances of mRNA expression due to inactivation of the promoter functions of the APC gene. 22 Such haploinsufficiences caused by reduced mRNA levels could be the results of epigenetic effects or mutations (deletions, insertions, ÔsilentÕ polymorphisms in transcription factor binding sites) in transcription regulatory regions of the APC gene. In this study, we did not experimentally test this possibility. Even when we scanned the entire coding region of the APC gene, other genes might be involved when we consider Gardner syndrome as an oligogenic disorder, or allow for modifier effects as has been anticipated for other apparently monogenic traits. [23] [24] [25] Screening for somatic mutations and ⁄ or loss of heterozygosity (LOH), which might also account for specific Gardner disease phenotypes, was not carried out as the patient did not present with intestinal polyps. Germline APC gene mutations have been shown to result in the occurrence of numerous intestinal polyps in the second or third decade of life. 26, 27 As a tumour suppressor, APC associates with the cadherin-binding protein b-catenin. 28 The non-mutated APC form is involved in the post-translational degradation of b-catenin which is somehow counteracted by the WNT-1 oncogene, 29, 30 and it has been proposed that tumour growth is at least in part due to deregulation of cytoplasmic b-catenin resulting from mutated APC.
The fact that the patient presented without intestinal polyposis may have some important implications for the interpretation of these results. Conceivably, the lack of functional germline mutations in the coding region of the APC gene may be compatible with the lack of intestinal manifestation. Moreover, the severity of Gardner disease phenotypes may correlate with the position of the mutation within the APC gene. 31 In that respect, APC gene mutations in the first or last third of the gene have been associated with an attenuated polyposis as well as a late onset of disease manifestations, 32, 33 whereas mutations in the central region of the gene correlate with a severe phenotype of thousands of polyps at a young age and with additional extracolonic manifestations. In this regard, it has been reported that the site of the germline mutation determines the type of Ôsecond hitÕ in intestinal tumours. 34 Patients with germline mutations near the so-called mutation cluster region (MCR), affecting codons 1250-1450 which represents only 8% of the entire coding sequence, tend to acquire their second hit by allelic loss and suffer more severe disease, 35 whereas mutations outside this region tend to be associated with truncating mutations. 36 Interestingly, extracolonic manifestations such as soft tissue tumours and osteomas do not correlate with the type or intragenic location of a particular germline mutation.
Except for D1822V, the polymorphisms we identified in our samples did not match the already published germline mutations in the APC gene. Wallis and colleagues 37 screened 190 unrelated FAP patients and 15 non-FAP colorectal cancer patients and found one FAP and two non-FAP patients to be homozygous for 1822V, whereas no other mutations in the APC gene could be identified. Interestingly, one non-FAP patient was an isolated case of colorectal cancer associated with CHRPE, whereas the second presented with a hepatic metastasis at the age of 60 and was subsequently shown to have between 30 and 40 adenomatous polyps in the descending and transverse colon. Additionally, in the latter study, spouses of 45 FAP patients were also screened for D1822V but no homozygote for the less frequent allele could be identified. The authors concluded that homozygous APC 1822V carriers might be at risk of developing colorectal cancer. This is most important because in the present study our patient, and also 11 of 194 (5AE7%) healthy individuals from the Glasgow area were 1822VV carriers. It is unlikely that the latter variant has an impact on Gardner disease, although a certain risk of developing colon cancer later in life may exist. This hypothesis can only be investigated in a prospective study design. The functional significance of the D1822V polymorphism remains to be shown; however, as it is located in the middle of the b-catenin downregulation domain, it may result in disruption of the putative cell signalling function of the APC protein. 30 In conclusion, from a genetic point of view, we consider our patient with multiple epidermal cysts, osteomas and a cold non-malignant nodule of the thyroid gland not to suffer from Gardner syndrome, because we failed to identify candidate germline mutations in > 8500 bp of the coding region of the APC gene 
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and major chromosomal deletions. However, we are aware of the fact that only mutation screening at the RNA level would be able to add more confidence to the statement that the APC gene is not inactivated in this patient. We could speculate that there is still about a 10% chance that a potential mechanism inactivating the APC gene has been missed because of the methodological limitations of the approach used for mutation screening in this case. From a clinical point of view, the patient may still have a risk of developing a thyroid carcinoma in the region of the cold nodule and even though he did not present with intestinal involvement at the time of the first examination, colonoscopy should be repeated annually, as it cannot be excluded that he will develop intestinal polyposis later in life.
